February 2, 2026
SOHO Insider Hem/Onc Library Leukemia Acute Myeloid Leukemia
SOHO Insider
ASH 2025 Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes Video Interviews

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

SOHO 2026
SOHO Asia 2026 Trending now Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026, receive early bird rates until June 10

ASH 2025 Cellular Therapy Leukemia Acute Myeloid Leukemia

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Belinda Avalos at ASH 2025
ASH 2025 Cellular Therapy Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas

Dr. Avalos highlights ASH 2025 takeaways, the future of blood cancer

ASH 2025 Leukemia Acute Myeloid Leukemia

Dr. Gruenbaum, of Blood Cancer United, discusses menin inhibitors in AML

Doctor holding an ipad
Trending now Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia News

Phase 1 study of menin inhibitor terminated early due to lack of response, differentiation syndrome

FDA Green light
Leukemia Acute Myeloid Leukemia

Novel AML product candidate granted orphan drug designation by FDA

FDA
Leukemia Acute Myeloid Leukemia

FDA approves revumenib in relapsed or refractory NMP1-mutated AML

FDA stamp on white paper
Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA accepts BLA for Orca-T in hematological malignancies

Leukemia News SOHO 2025 Educational Resources Acute Myeloid Leukemia Meetings / Conferences News

Future Role of CPX-351 and CPX-351-Based Combinations